IN8BIO, INC. (INAB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$12.71M | +47.4% |
| 2024 | -$24.15M | -3.5% |
| 2023 | -$23.34M | +3.2% |
| 2022 | -$24.12M | -78.6% |
| 2021 | -$13.51M | -89.4% |
| 2020 | -$7.13M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$12.71M | +47.4% |
| 2024 | -$24.15M | -3.5% |
| 2023 | -$23.34M | +3.2% |
| 2022 | -$24.12M | -78.6% |
| 2021 | -$13.51M | -89.4% |
| 2020 | -$7.13M | — |